Global Journal of Integrated Chinese Medicine and Western Medicine

Global Journal of Integrated Chinese Medicine and Western Medicine is an international, open access, peer-reviewed academic journal, which focuses the practice and research of integrated Chinese medicine and western medicine, with its ISSN 2308-6025(print)  ISSN 2375-4710(Online). All the papers are available for download on the journal’s webpage, free of charge.It mainly publishes articles concerning the latest development, review and exchange of experience about integrated Chinese medicine and western medicine. It has been dedicated exclusively to the exchange of information regarding the development of integrated Chinese medicine and western medicine. This approach to dissemination of information will serve to improve human health. 


We expect all authors submitting to Global Journal of Integrated Chinese Medicine and Western Medicine to adhere to the following ethical guidelines:

A. All authors must warrant that their article is their own original work, which does not infringe the intellectual property rights of any other person or entity, and cannot be construed as plagiarizing any other published work, including their own previously published work.

B. All authors named on the paper are equally held accountable for the content of a submitted manuscript or published paper.

C. The corresponding author must ensure all named co-authors consent to publication and to being named as a co-author. All persons who have made significant scientific or literary contributions to the work reported should be named as co-authors.

D. Authors must not submit a manuscript to more than one journal simultaneously.

E. Authors should not submit previously published work, nor work which is based in substance on previously published work, either in part or whole.

F. Authors must appropriately cite all relevant publications. Information obtained privately, as in conversation, correspondence, or discussion with third parties, should not be used or reported in the author's work unless fully cited, and with the permission of that third party.

G. Authors must make available all necessary formal and documented ethical approval from an appropriate research ethics committee, including evidence of anonymization and informed consent from the client(s) or patient(s) studied, if appropriate.

H. Authors must follow national and international procedures that govern the ethics of experimentation on humans and animals. Research reported in the paper must be conducted in an ethical and responsible manner, in full compliance with all relevant codes of experimentation and legislation. All papers which report in vivo experiments or clinical trials on humans or animals must include a written statement in the Methods section that such work was conducted with the formal approval of the local human subject or animal care committees, and that clinical trials have been registered as legislation requires.

I. Authors must include all appropriate warnings concerning any specific and particular hazards that may be involved in carrying out experiments or procedures described in the article or involved in instructions, materials, or formulae in the article; include explicitly relevant safety precautions, and cite, if an accepted standard or code of practice is relevant, a reference to the relevant standard or code.

J. If required, authors must facilitate access to data sets described in the article.

K. Authors must avoid making defamatory statements in submitted articles which could be construed as impugning any person's reputation.

L. Authors must declare any potential conflict of interest – be it professional or financial – which could be held to arise with respect to the article.

M. Authors must disclose all sources of funding for the research reported in the paper.

N. If asked to provide a list of suggested reviewers, authors must provide the correct details for suitable reviewers with the appropriate experience to review, ensuring that the suggested reviewers do not have a conflict of interest.






Posted: 2016-07-01



5月29日上午,第四届“京交会”中医药服务主题日启动仪式暨海外华侨华人中医药大会在北京国际会议中心隆重开幕。大会主题是“‘传承 服务 创新’——中医药,献给世界的礼物”,来自世界五个大洲、49个国家和地区的210名海外华侨华人代表参加大会。

Posted: 2016-05-31




Posted: 2016-04-29

中医药再登博鳌论坛 “走出去”离不开科技创新



Posted: 2016-04-01




Posted: 2016-03-02



1月21日在达沃斯举行了“万物互联和下一代中国制造”主题晚宴,讨论工业4.0对全球不同国家和行业的影响,尤其是中国在其中的机遇。广州医药集团董事长李楚源出席晚宴并针对医药健康产业发表演讲。同时出席晚会的还有清华大学教授李稻葵、北京大学教授张维迎、联想集团董事长兼总裁杨元庆、百度公司总裁张亚勤、IDG合伙人熊晓鸽、Uber首席商务官Emil Michael等众多嘉宾。

Posted: 2016-01-28
More Announcements...

Vol 5, No 1 (2017)

Table of Contents


Awareness of the risk factors for octagon glaucoma PDF (简体中文)
Li-qing Lu, Li-ping Chen, Xin Qi, Wei Zhao

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.

Global Journal of Integrated Chinese Medicine and Western Medicine

ISSN 2308-6025 (Print)  ISSN 2375-4710 (Online)

Office Phone: NewYork:+1 (212) 401-5998; Michigan:+1 (248) 524-0321
Office FAX: NewYork:+1 (212) 401-5997 Michigan:+1 (248) 680-6699
Mailing address: 82 Nassau Street, #458, New York, NY 10038
Office address: Liberty Center,100 W Big Beaver Rd, Suite 200,Troy, MI 48084
Copyright ©2022 New Century Science Press LLC, All rights reserved
New Century Science Press (NCSP) is an academic press publishing international academic journals based on open access